Charles Rosier in Supporting Health
When Baulieu and his co-workers were experiencing financial difficulties on developing a new drug, he funded them. He also invested capital in the laboratory of Mapreg, situated in Paris, to continue performing studies about some serious conditions including depression and stroke. The investment by Charles Rosier allowed them to do studies and, because of that, he was given a specific profit-share. With his determination to contribute to the medical industry, Charles Rosier voluntarily invested in the Mapreg Drug Project.
BTG Pactual is an investment bank in Latin America, for whom Charles Rosier became a partner. GMS (Goldman Sachs) is a leading investment bank that operates around the world. As their Managing Director, he focused on handling public assets. He worked as a partner at BTG Pactual Bank, a financial institution which has 30 years of experience in international markets, appointing about 2,500 individuals spread across Latin America.
The appointment of Charles Rosier at Lehman Brothers in 1996 was his first step towards a brilliant future. He became the manager of their Debt Capital Market Division at UBS Warburg in 1997. BTG Pactual has been respected in international markets for more than 30 years now and has 2,500 personnel throughout Latin America. In 1999, Goldman Sachs (GMS) offered him a new job opportunity. After accepting the offer, he was appointed as their Managing Director. In August 2010, Charles Rosier became a member of BTG Pactual. He became a partner at BTG Pactual, an investment bank located in Latin America.
How Charles Rosier Was Educated
To get additional training and to prepare for further French education, Charles Rosier studied hard for another two years. He finished his secondary education in 1991 at Paris’s Fenelon Sainte-Marie. When Charles Rosier gained his degree at ESCP Europe, it became the gateway to establishing his own chosen profession.